日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

在卵巢上皮癌细胞系中过度表达 CCL2 趋化因子会导致体内致瘤性的潜伏

Wojnarowicz P, Gambaro K, de Ladurantaye M, Quinn M C J, Provencher D, Mes-Masson A-M, Tonin P N

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

BRCA1/2相关乳腺癌对新辅助化疗有显著反应

Chappuis, P O; Goffin, J; Wong, N; Perret, C; Ghadirian, P; Tonin, P N; Foulkes, W D

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

法国加拿大乳腺癌和卵巢癌家族中的BRCA1和BRCA2基因突变

Tonin, P N; Mes-Masson, A M; Futreal, P A; Morgan, K; Mahon, M; Foulkes, W D; Cole, D E; Provencher, D; Ghadirian, P; Narod, S A

Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon

患有乳腺癌和结肠癌双原发癌的女性的一级亲属患癌风险增加。

Foulkes, W D; Bolduc, N; Lambert, D; Ginsburg, O; Olien, L; Yandell, D W; Tonin, P N; Narod, S A